6CM
MDCO

683 Capital Management’s Medicines Co MDCO Stock Holding History

683 Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-215,000
Closed -$7.84M – 177
2019
Q2 		$7.84M Buy
215,000
+47,748
+29% +$1.56M 0.71% 39
2019
Q1 		$4.67M Hold
167,252
– – 0.42% 53
2018
Q4 		$3.2M Hold
167,252
– – 0.19% 74
2018
Q3 		$5M Buy
167,252
+40,000
+31% +$1.51M 0.32% 55
2018
Q2 		$4.67M Buy
127,252
+10,000
+9% +$325K 0.32% 57
2018
Q1 		$3.86M Buy
117,252
+67,252
+135% +$2.1M 0.34% 62
2017
Q4 		$1.37M Buy
+50,000
New +$1.54M 0.12% 101

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

683 Capital Management's MDCO Position: Q3 2019 in Review

683 Capital Management sold out of Medicines Co (MDCO) in Q3 2019, closing a stake of 215,000 shares — an estimated $7.84M sold.

683 Capital Management first reported a position in MDCO in Q4 2017 and held it in 7 quarters. The position peaked at $7.84M in Q2 2019. 250 funds tracked by Wall St. Rank hold MDCO as of Q3 2019.

  • 683 Capital Management reported no remaining Medicines Co position as of Q3 2019 after selling out during the quarter.
  • 683 Capital Management sold 215,000 Medicines Co shares in Q3 2019, an estimated $7.84M.
  • 683 Capital Management first reported a position in Medicines Co in Q4 2017 and held it in 7 quarters.
  • 683 Capital Management's Medicines Co position peaked at $7.84M in Q2 2019.
  • 250 funds tracked by Wall St. Rank held Medicines Co as of Q3 2019.

Based on 683 Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.